160 related articles for article (PubMed ID: 2822378)
1. Specific receptors for alpha-melanocyte-stimulating hormone are widely distributed in tissues of rodents.
Tatro JB; Reichlin S
Endocrinology; 1987 Nov; 121(5):1900-7. PubMed ID: 2822378
[TBL] [Abstract][Full Text] [Related]
2. Melanotropin receptors of murine melanoma characterized in cultured cells and demonstrated in experimental tumors in situ.
Tatro JB; Entwistle ML; Lester BR; Reichlin S
Cancer Res; 1990 Feb; 50(4):1237-42. PubMed ID: 2153454
[TBL] [Abstract][Full Text] [Related]
3. Interaction of an alpha-melanocyte-stimulating hormone-diphtheria toxin fusion protein with melanotropin receptors in human melanoma metastases.
Tatro JB; Wen Z; Entwistle ML; Atkins MB; Smith TJ; Reichlin S; Murphy JR
Cancer Res; 1992 May; 52(9):2545-8. PubMed ID: 1314697
[TBL] [Abstract][Full Text] [Related]
4. Binding and internalization of the melanocyte stimulating hormone receptor ligand [Nle4, D-Phe7] alpha-MSH in B16 melanoma cells.
Wong W; Minchin RF
Int J Biochem Cell Biol; 1996 Nov; 28(11):1223-32. PubMed ID: 9022281
[TBL] [Abstract][Full Text] [Related]
5. Melanotropin receptors in the brain are differentially distributed and recognize both corticotropin and alpha-melanocyte stimulating hormone.
Tatro JB
Brain Res; 1990 Dec; 536(1-2):124-32. PubMed ID: 1964830
[TBL] [Abstract][Full Text] [Related]
6. Characterization of functional melanotropin receptors in lacrimal glands of the rat.
Entwistle ML; Hann LE; Sullivan DA; Tatro JB
Peptides; 1990; 11(3):477-83. PubMed ID: 2166277
[TBL] [Abstract][Full Text] [Related]
7. Radioiodination of rhenium cyclized alpha-melanocyte-stimulating hormone resulting in enhanced radioactivity localization and retention in melanoma.
Cheng Z; Chen J; Quinn TP; Jurisson SS
Cancer Res; 2004 Feb; 64(4):1411-8. PubMed ID: 14973076
[TBL] [Abstract][Full Text] [Related]
8. [111In]-DTPA-labeled analogues of alpha-melanocyte-stimulating hormone for melanoma targeting: receptor binding in vitro and in vivo.
Bagutti C; Stolz B; Albert R; Bruns C; Pless J; Eberle AN
Int J Cancer; 1994 Sep; 58(5):749-55. PubMed ID: 8077062
[TBL] [Abstract][Full Text] [Related]
9. Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.
Chen J; Cheng Z; Hoffman TJ; Jurisson SS; Quinn TP
Cancer Res; 2000 Oct; 60(20):5649-58. PubMed ID: 11059756
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the internalization of [125I-Tyr2, Nle4, D-Phe7] alpha-MSH following binding to the MSH receptor of B16 murine melanoma cells.
Adams G; Olivier GW; Branch SK; Moss SH; Notarianni LJ; Pouton CW
Ann N Y Acad Sci; 1993 May; 680():440-1. PubMed ID: 8390163
[No Abstract] [Full Text] [Related]
11. Enhanced binding and inertness to dehalogenation of alpha-melanotropic peptides labeled using N-succinimidyl 3-iodobenzoate.
Garg PK; Alston KL; Welsh PC; Zalutsky MR
Bioconjug Chem; 1996; 7(2):233-9. PubMed ID: 8983345
[TBL] [Abstract][Full Text] [Related]
12. Fluorine-18-labeled [Nle4,D-Phe7]-alpha-MSH, an alpha-melanocyte stimulating hormone analogue.
Vaidyanathan G; Zalutsky MR
Nucl Med Biol; 1997 Feb; 24(2):171-8. PubMed ID: 9089709
[TBL] [Abstract][Full Text] [Related]
13. alpha-MSH receptor autoradiography on mouse and human melanoma tissue sections and biopsies.
Bagutti C; Oestreicher M; Siegrist W; Oberholzer M; Eberle AN
J Recept Signal Transduct Res; 1995; 15(1-4):427-42. PubMed ID: 8903955
[TBL] [Abstract][Full Text] [Related]
14. A novel DOTA-alpha-melanocyte-stimulating hormone analog for metastatic melanoma diagnosis.
Froidevaux S; Calame-Christe M; Tanner H; Sumanovski L; Eberle AN
J Nucl Med; 2002 Dec; 43(12):1699-706. PubMed ID: 12468522
[TBL] [Abstract][Full Text] [Related]
15. Melanotropin receptors demonstrated in situ in human melanoma.
Tatro JB; Atkins M; Mier JW; Hardarson S; Wolfe H; Smith T; Entwistle ML; Reichlin S
J Clin Invest; 1990 Jun; 85(6):1825-32. PubMed ID: 2347915
[TBL] [Abstract][Full Text] [Related]
16. Photoaffinity labelling of melanoma cell MSH receptors.
Scimonelli T; Eberle AN
FEBS Lett; 1987 Dec; 226(1):134-8. PubMed ID: 3691812
[TBL] [Abstract][Full Text] [Related]
17. [Nle4, D-Phe7]-alpha-MSH: a superpotent melanotropin that "irreversibly" activates melanoma tyrosinase.
Hadley ME; Abdel Malek ZA; Marwan MM; Kreutzfeld KL; Hruby VJ
Endocr Res; 1985; 11(3-4):157-70. PubMed ID: 3009169
[TBL] [Abstract][Full Text] [Related]
18. Use of an alpha-melanocyte-stimulating hormone analogue to improve alpha-melanocyte-stimulating hormone receptor binding assay in human melanoma.
Libert A; Ghanem G; Arnould R; Lejeune FJ
Pigment Cell Res; 1989; 2(6):510-8. PubMed ID: 2557606
[TBL] [Abstract][Full Text] [Related]
19. The melanocortin receptor in the rat lacrimal gland: a model system for the study of MSH (melanocyte stimulating hormone) as a potential neurotransmitter.
Leiba H; Garty NB; Schmidt-Sole J; Piterman O; Azrad A; Salomon Y
Eur J Pharmacol; 1990 May; 181(1-2):71-82. PubMed ID: 1974859
[TBL] [Abstract][Full Text] [Related]
20. Characterization of receptors for alpha-melanocyte-stimulating hormone on human melanoma cells.
Siegrist W; Solca F; Stutz S; Giuffrè L; Carrel S; Girard J; Eberle AN
Cancer Res; 1989 Nov; 49(22):6352-8. PubMed ID: 2804981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]